RxDoctor Payments DataLook up a doctor →

Sunil Dhawan, MD

Dermatology · Fremont, CANPI 1326018987

Payments from drug & device makers

$5,034,302in general payments, 2019–2025

Across 1,684 payments — averaging $2989.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$911K
  • Incyte Corporation$569K
  • AbbVie$530K
  • Sanofi US Services Inc.$297K
  • Takeda Pharmaceuticals U.S.A., Inc.$282K
  • Bausch Health US, LLC$266K
  • plus $2.2M from 45 others
$39,236in research payments, 2019–2025

Across 12 payments — averaging $3269.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bausch Health US, LLC$21K
  • Eli Lilly$18K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly56$911,288
Incyte Corporation177$568,811
AbbVie(2 entities)192$530,092
Sanofi US Services Inc.64$297,473
Takeda Pharmaceuticals U.S.A., Inc.30$281,748
Bausch Health US, LLC37$265,554
Janssen Research & Development, LLC62$263,957
Amgen39$244,037
Vanda Pharmaceuticals Inc.25$203,179
Kiniksa Pharmaceuticals, Ltd.80$200,121
Novartis27$195,036
Sun Pharmaceutical Industries Inc.74$167,183
E.r. Squibb & Sons, L.L.C.21$143,039
Regeneron88$101,387
Acrotech Biopharma Inc.13$87,702
Teva Pharmaceuticals USA, Inc.13$85,312
LEO Pharma AS17$70,358
Taro Pharmaceuticals USA, Inc.29$68,136
Journey Medical Corporation9$66,948
VYNE Pharmaceuticals Inc.32$65,449
Pfizer93$61,557
Kiniksa Pharmaceuticals International, PLC2$32,673
Galderma Research & Development, LLC5$21,311
Dermira, Inc.12$20,672
Arcutis Biotherapeutics, Inc.10$17,313
Boehringer Ingelheim3$16,720
Dermavant Sciences, Inc.100$15,113
Dr.reddy's Laboratories,inc.6$11,206
Mayne Pharma Commercial LLC16$7,576
UCB SA3$4,558
Ortho Dermatologics, A Division Of Bausch Health US, LLC69$2,877
LEO Pharma Inc.106$1,334
Johnson & Johnson49$1,015
Almirall LLC6$992
Lilly USA, LLC29$521
Galderma Laboratories, L.p.14$489
Sanofi10$383
Regeneron Healthcare Solutions, Inc.12$286
Biofrontera Inc.13$185
Organogenesis Inc.6$157
UCB, Inc.6$115
Strata Skin Sciences, Inc.5$103
EPI Health, LLC6$102
Organon9$76
Janssen Scientific Affairs, LLC2$34
DUSA Pharmaceuticals, Inc.2$30
Merck1$26
Bristol Myers Squibb1$21
Promius Pharma LLC1$20
Verrica Pharmaceuticals Inc.1$17
Eli Lilly Export S.A. Puerto Rico Branch1$14

How this compares

$5,034,302 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California

Medicare billing

Part B allowed, 2024
$598,363
Medicare patients
1,258
Services billed
20,106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Fremont

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →